Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia 10Burkitt Lymphoma 9Recurrence 8Lymphoproliferative Disorders 6Lymphoma, Non-Hodgkin 5Lymphatic Diseases 5Immunoproliferative Disorders 4Neoplasms 3Neoplasm, Residual 3Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Lymphoid 2Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Large Granular Lymphocytic 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Hematologic Neoplasms 1Bites and Stings 1

Interventions

ibrutinib 4fludarabine phosphate 4fludarabine 4Rituximab 4Bendamustine Hydrochloride 3blinatumomab 2Melphalan 2Lenalidomide 2Cyclophosphamide 2Busulfan 2Alemtuzumab 2thymoglobulin 1sargramostim 1pirtobrutinib 1pegaspargase 1palbociclib 1ofatumumab 1obinutuzumab 1lirilumab 1copanlisib 1Vincristine 1RFT5-SMPT-dgA immunotoxin 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Methotrexate 1Mesna 1Leukapheresis 1Immunotherapy, Adoptive 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Lymphoid × blinatumomab × Clear all
NCT01466179 2017-08-18

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Amgen Research (Munich) GmbH

Phase 2 Completed
225 enrolled 24 charts
LymphoidOther hematologic neoplasm

Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01471782 2017-02-08

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Amgen Research (Munich) GmbH

Phase 1/2 Completed
93 enrolled 21 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡